Literature DB >> 28859303

Context-dependent signalling in platelets in vascular diseases: ROCK2 around thrombosis.

János G Filep1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28859303      PMCID： PMC5852530          DOI： 10.1093/cvr/cvx141

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN： 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  15 in total

Review 1.  Platelets as immune cells: bridging inflammation and cardiovascular disease.

Authors:  Philipp von Hundelshausen; Christian Weber
Journal:  Circ Res       Date:  2007-01-05       Impact factor: 17.367

Review 2.  Platelet activation and atherothrombosis.

Authors:  Giovanni Davì; Carlo Patrono
Journal:  N Engl J Med       Date:  2007-12-13       Impact factor: 91.245

3.  Rho-associated coiled-coil-containing kinase 2 deficiency in bone marrow-derived cells leads to increased cholesterol efflux and decreased atherosclerosis.

Authors:  Qian Zhou; Yu Mei; Takuhito Shoji; Xinbing Han; Karol Kaminski; Goo Taeg Oh; Pat P Ongusaha; Kunzhong Zhang; Hannah Schmitt; Martin Moser; Christoph Bode; James K Liao
Journal:  Circulation       Date:  2012-09-25       Impact factor: 29.690

4.  Targeted disruption of the mouse rho-associated kinase 2 gene results in intrauterine growth retardation and fetal death.

Authors:  Dean Thumkeo; Jeongsin Keel; Toshimasa Ishizaki; Masaya Hirose; Kimiko Nonomura; Hiroko Oshima; Masanobu Oshima; Makoto M Taketo; Shuh Narumiya
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

5.  Increased leukocyte ROCK activity in patients after acute ischemic stroke.

Authors:  Steven K Feske; Farzaneh A Sorond; Galen V Henderson; Minoru Seto; Asako Hitomi; Koh Kawasaki; Yasuo Sasaki; Toshio Asano; James K Liao
Journal:  Brain Res       Date:  2008-12-25       Impact factor: 3.252

Review 6.  Rho GTPases in platelet function.

Authors:  J E Aslan; O J T McCarty
Journal:  J Thromb Haemost       Date:  2013-01       Impact factor: 5.824

Review 7.  Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease.

Authors:  Steven R Steinhubl; Juan J Badimon; Deepak L Bhatt; Jean-Marc Herbert; Thomas F Lüscher
Journal:  Vasc Med       Date:  2007-05       Impact factor: 3.239

8.  Rho-associated kinase activity is a predictor of cardiovascular outcomes.

Authors:  Masato Kajikawa; Kensuke Noma; Tatsuya Maruhashi; Shinsuke Mikami; Yumiko Iwamoto; Akimichi Iwamoto; Takeshi Matsumoto; Takayuki Hidaka; Yasuki Kihara; Kazuaki Chayama; Ayumu Nakashima; Chikara Goto; James K Liao; Yukihito Higashi
Journal:  Hypertension       Date:  2013-12-30       Impact factor: 10.190

9.  Rho-associated protein kinase contributes to early atherosclerotic lesion formation in mice.

Authors:  Ziad Mallat; Andrea Gojova; Vincent Sauzeau; Valérie Brun; Jean-Sébastien Silvestre; Bruno Esposito; Régine Merval; Hervé Groux; Gervaise Loirand; Alain Tedgui
Journal:  Circ Res       Date:  2003-10-02       Impact factor: 17.367

10.  Decreased thromboembolic stroke but not atherosclerosis or vascular remodelling in mice with ROCK2-deficient platelets.

Authors:  Nikola Sladojevic; Goo Taeg Oh; Hyung-Hwan Kim; Lea M Beaulieu; Hervé Falet; Karol Kaminski; Jane E Freedman; James K Liao
Journal:  Cardiovasc Res       Date:  2017-09-01       Impact factor: 10.787
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.